ARTICLE | Clinical News
Abraxane paclitaxel plus albumin regulatory update
May 17, 2004 7:00 AM UTC
FDA accepted for filing an NDA from APPX for Abraxane to treat metastatic breast cancer. Abraxane is a nanoparticle comprising paclitaxel bound to albumin that avoids the use of solvents with paclitax...